Nearly 1 in 3 COVID-19 Vaccine Recipients Suffered Neurological Side Effects
By Naveen Athrappully Almost a third of individuals who received a COVID-19 vaccine suffered from neurological complications including tremors, insomnia, and muscle spasms, according to a recent study published in the journal Vaccines. Dr. Peter McCullough wrote about the study in an article on Substack. “A shocking 31.2 percent of respondents to this large dataset sustained neurologic injury…
More Stories
Various Eateries (LON:VARE) Shares Down 2.8% – Time to Sell?
Shares of Various Eateries PLC (LON:VARE – Get Free Report) dropped 2.8% during trading on Friday . The stock traded...
Microlise Group (LON:SAAS) Stock Price Down 2.5% – Here’s Why
Microlise Group plc (LON:SAAS – Get Free Report) dropped 2.5% on Friday . The stock traded as low as GBX...
Nuvera Communications (OTCMKTS:NUVR) Shares Up 1.3% – Still a Buy?
Shares of Nuvera Communications, Inc. (OTCMKTS:NUVR – Get Free Report) rose 1.3% during trading on Friday . The stock traded...
Steppe Gold (OTCMKTS:STPGF) Trading Up 5% – Should You Buy?
Steppe Gold Ltd. (OTCMKTS:STPGF – Get Free Report) rose 5% during trading on Friday . The company traded as high...
AdvisorShares Q Dynamic Growth ETF (NYSEARCA:QPX) Trading Up 0.4% – What’s Next?
AdvisorShares Q Dynamic Growth ETF (NYSEARCA:QPX – Get Free Report)’s stock price shot up 0.4% during mid-day trading on Friday...
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund (NYSEARCA:CORP) Shares Up 0.1% – Time to Buy?
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund (NYSEARCA:CORP – Get Free Report) rose 0.1% during trading on Friday ....